Monitoring of Stability of the Live Plague Vaccine Produced Using Condensed Corn Steep Extract Hydrolysate-Based Nutrient Medium
https://doi.org/10.21055/0370-1069-2019-4-37-40
Abstract
Objective of the study was to analyze the stability of the preparation of a live plague vaccine made using an experimental nutrient medium over its shelf life. Materials and methods. A series of live plague vaccine based on Yersinia pestis EV NIIEG strain prodused using experimental nutrient medium were utilized in this work. Most significant qualitative parameters of the preparation were studied: microbe cell content, viability, thermal stability, mass loss during the process of drying, and immunogenicity. Results and discussion. The stability of the vaccine produced using the nutrient medium based on hydrolysate of condensed corn steep extract was monitored over a specified shelf life (three years). A comparative analysis of the viability of all experimental vaccine series was carried out at certain time intervals - short-term storage (up to 3 months) and before the expiration date. During storage, there was an insignificant decrease in the percentage of living microbial cells, while in no series the viability decrease reached below the regulated levels of 25 %. Such a decrease is natural for a “live preparation” and is not critical within the obtained limits. The rest of the studied indicators practically did not change. Thus, the analysis of the data obtained indicates that in all the periods of observation the drug retained the stability of the main regulated indicators. The studies confirm the feasibility of using this referred nutrient medium based on hydrolyzed corn steep extract in industrial production of the plague live vaccine preparation.
About the Authors
S. E. GostishchevaRussian Federation
Svetlana E. Gostishcheva.
13-15, Sovetskaya St., Stavropol, 355035.
N. V. Abzaeva
Russian Federation
13-15, Sovetskaya St., Stavropol, 355035.
G. F. Ivanova
Russian Federation
13-15, Sovetskaya St., Stavropol, 355035.
L. S. Katunina
Russian Federation
13-15, Sovetskaya St., Stavropol, 355035.
D. V. Rostovtseva
Russian Federation
13-15, Sovetskaya St., Stavropol, 355035.
A. V. Kostrominov
Russian Federation
13-15, Sovetskaya St., Stavropol, 355035.
References
1. Verma S.K., Tuteja U. Plague vaccine development: current research and future trends. Front. Immunol. 2016; 7:602. DOI: 10.3389/fimmu.2016.00602.
2. Byvalov A.A., Kutyrev V.V. [Current state of the problem of improving the means of vaccine prophylaxis of plague]. Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii [Journal of Microbiology, Epidemiology and Immunobiology]. 2011; (2):97-104.
3. Williamson E.D., Oyston PC. Protecting against plague: to-wards a next-generation vaccine. Clin. Exp. Immunol. 2013; 172(1): 1-8. DOI: 10.1111/cei.12044.
4. Polyak M.S., Sukharevich VI., Sukharevich M.E. [Nutrient media for medical and sanitary microbiology]. “Elbi-SPb”; 2008. 352 p.
5. Mikhailova V.S., Polyak M.S., Sukhanova S.M. [On the role of intralaboratory quality control in the standardization of nutrient media for microbiological research in clinical diagnostic laboratories]. Problemy Standartizatsii v Zdravookhranenii [Problems of Standardization in Healthcare]. 2009; 5(6):8-15.
6. Bashkirova S.N., Pogrebnyak A.V., Stepanova E.F. [Theoretical assessment of the mutual influence of the components on the overall stability of the drug]. Vestnik Novykh Meditsinskhih Tekhnologiy [Bulletin of New Medical Technologies]. 2006; 13(1):102-4.
7. Jadhav S.S., Dogar V, Gautam M., Gairola S. Stability testing of vaccines: Developing Countries Vaccine Manufacturers’ Network (DCVMN) perspective. Biologicals. 2009; 37(6):360-3. DOI: 10.1016/j.biologicals.2009.08.003._
8. Pfleiderer M. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - An always reliable approach? Biologicals. 2009; 37(6):364-8. DOI: 10.1016/j.biologicals.2009.08.013.
9. Kasina I.V., Alekseeva S.A., Fadeykina O.V., Nemirovskaya T.I., Volkova R.A. [Certification of a new series of industry standard sample to control the specific activity and thermostability of the plague live vaccine]. BIOpreparaty. Profilaktika, Diagnostika, Lechenie [BIOpreparations. Prevention, Diagnosis, Treatment]. 2018; 18(4):262-7. DOI: 10.30895/2221-996X-2018-18-4-262-267.
10. Davydov D.S. [Analysis of stability indicators of biological drug quality during the tests in the framework of conformity assessment]. BIOpreparaty. Profilaktika, Diagnostika, Lechenie [BIOpreparations. Prevention, Diagnosis, Treatment]. 2017; 17(4):230-2
11. Sakaeva I.V., Bunyatyan N.D., Kovaleva E.L., Sakanyan E.I., Mit’kina L.I., Prokopov IA., Shelekhina E.S., Mit’kina Yu.V [The main approaches to the study of drug stability: domestic and international experience]. Vedomosti Nauchnogo Tsentra Ekspertizy Sredstv Meditsinskogo Primeneniya [The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products] 2013; (3):8-11.
12. Kolyshkin V.M., Vasil’ev A.V. [Assessment of the stability of measles vaccine production]. Biotekhnologiya [Biotechnology]. 2008; (1):57-63.
13. Nikolaeva L.L., Gulyakin I.D., Orlova O.L., Polozkova A.P, Oborotova N.A., Sanarova E.V., Lantsova A.V, Khlamov V.V, Bunyatyan N.D. [Lyophilization as a way to stabilize drugs (review)]. Khiniko-Farmatsevtichesky Zhurnal [Chemical Pharmaceutical Journal]. 2017; (4):54-9. DOI: 10.30906/0023-1134-2017-51-4-54-58.
14. Komissarov A.V., Bibikov D.N., Volokh O.A., Badarin S.A., Sinitsyna N.V., Kostyleva N.I., Germanchuk V.G., Nikiforov A.K. [Lyophilization of live vaccines]. Vestnik Biotekhnologii i Fiziko-Khinicheskoi Biologii im. Yu.A. Ovchinnikova [Yu.A. Ovchinnikov Bulletin of Biotechnology and Physical-Chemical Biology]. 2018; 14(3):56-73.
15. Faibich M.M. [Stabilization of vaccines in the process of drying and storage]. Uspekhi Mikrobiologii [Advances in Microbiology]. 1983; (18):193-215.
16. Beker M.E., Damberg B.E., Rapoport A.I. [Anabiosis of microorganisms]. Riga: «Zinatne», 1981. 246 p.
17. Ostrovsky D.N., Kapel’yants A.S., Lukoyanova M.A. [Applied aspects of the biochemistry of membranes]. Prikladnaya Biokhimia iMikrobiologia [Applied Biochemistry and Microbiology]. 1983; 19(1):60-70.
18. Gostishcheva S.E., Abzaeva N.V., Ivanova G.F., Rostovtseva D.V., Katunina L.S., Zuenko A. A. [Quality assessment of the live plague vaccine prepared using nutrient medium on the basis of the hydrolysate of concentrated corn steep]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2018; (3): 46-9.
19. [The State Pharmacopoeia of the Russian Federation, XIV edition]. Moscow; 2018. Vol. 1.
Review
For citations:
Gostishcheva S.E., Abzaeva N.V., Ivanova G.F., Katunina L.S., Rostovtseva D.V., Kostrominov A.V. Monitoring of Stability of the Live Plague Vaccine Produced Using Condensed Corn Steep Extract Hydrolysate-Based Nutrient Medium. Problems of Particularly Dangerous Infections. 2019;(4):37-40. (In Russ.) https://doi.org/10.21055/0370-1069-2019-4-37-40